idsMED Singapore Showcases Innovative Solutions at the 19th ASNO Annual Meeting

The 19^th Asian Society for Neuro-Oncology (ASNO) Annual Meeting “Coming Together for Our Patients”, was held at the One Farrer Hotel, Singapore from 16 – 18 August 2024. The event, jointly organised by the Singapore Society of Neuro-Oncology (SSNO) and ASNO, provided a platform for regional and international medical professionals, including neurosurgeons, neurologists, oncologists, nurses, medical students, scientists, and radiologists—to converge, exchange knowledge and explore innovative approaches in neuro-oncology.

Before the Main Conference, a Pre-Conference was held on 14 and 15 August 2024 at the National University Hospital, focusing primarily on providing comprehensive updates on managing common neurosurgical conditions.

idsMED Singapore showcased a range of cutting-edge and innovative products related to neuro-oncology, aimed at enhancing the quality of care for patients with brain and spinal tumours.

The idsMED Singapore Field Sales Specialist (FSS) and Medical Specialty Care (MSC) teams, who were present both at the Pre- and Main Conference, took full advantage of the event to share updates on the latest technologies and demonstrate the effectiveness of the products to the participants.

The collaborative environment fostered at the conference enriched the overall experience, creating a comprehensive and engaging atmosphere for participants and industry partners alike, as they forge lasting connections.

About ASNO, SSNO and JSNO

The Asian Society for Neuro-Oncology (ASNO) is a prominent organisation with a global reputation, dedicated to pushing the boundaries of neuro-oncology through cutting-edge research and innovation.

The Singapore Society of Neuro-Oncology (SSNO) is committed to improving the lives of patients with neuro-oncological conditions through research, education, and collaboration, focusing on advancing the field of neuro-oncology within the vibrant landscape of Singapore.

Emphasising active participation and collaboration, a joint session between SSNO and the Japan Society for Neuro-Oncology (JSNO) is scheduled during the ASNO 2024 to share insights, and research advancements, and foster a broader network within the neuro-oncology community.